{"id":"https://openalex.org/W7095744286","doi":null,"title":"SUMMARY","display_name":"SUMMARY","publication_year":2016,"publication_date":"2016-09-08","ids":{"openalex":"https://openalex.org/W7095744286"},"language":"en","primary_location":{"id":"pmh:oai:CiteSeerX.psu:10.1.1.859.6217","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.859.6217","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://orbi.ulg.ac.be/bitstream/2268/12358/1/DT2%20PREVENTION%20BOOK%202006%20final.pdf","raw_type":"text"},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039563874","display_name":"Andr\u00e9 Jacques Scheen","orcid":"https://orcid.org/0000-0001-9743-4371","observed_orcids":["https://orcid.org/0000-0001-9743-4371"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andr\u00e9 J. Scheen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Address Prof","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Address Prof","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.8730000257492065,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.8730000257492065,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.11060000211000443,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.008299999870359898,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes-prevention","display_name":"type 2 diabetes prevention","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pharmacological-prophylaxis","display_name":"pharmacological prophylaxis","score":0.7409999966621399},{"id":"https://openalex.org/keywords/impaired-glucose-tolerance","display_name":"impaired glucose tolerance","score":0.8610000014305115},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.9340000152587891},{"id":"https://openalex.org/keywords/acarbose","display_name":"acarbose","score":0.9990000128746033},{"id":"https://openalex.org/keywords/thiazolidinediones","display_name":"thiazolidinediones","score":0.9990000128746033},{"id":"https://openalex.org/keywords/orlistat","display_name":"orlistat","score":0.8510000109672546},{"id":"https://openalex.org/keywords/sibutramine","display_name":"sibutramine","score":0.9100000262260437},{"id":"https://openalex.org/keywords/rimonabant","display_name":"rimonabant","score":0.9990000128746033},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.7620000243186951},{"id":"https://openalex.org/keywords/fibrates","display_name":"fibrates","score":0.9879999756813049},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.9300000071525574},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.6290000081062317},{"id":"https://openalex.org/keywords/lifestyle-intervention","display_name":"lifestyle intervention","score":0.8510000109672546},{"id":"https://openalex.org/keywords/high-risk-individuals","display_name":"high-risk individuals","score":0.8989999890327454}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8726999759674072},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.7421000003814697},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5304999947547913},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5016000270843506},{"id":"https://openalex.org/C2776617576","wikidata":"https://www.wikidata.org/wiki/Q338005","display_name":"Acarbose","level":3,"score":0.4724999964237213},{"id":"https://openalex.org/C2777646958","wikidata":"https://www.wikidata.org/wiki/Q424151","display_name":"Sibutramine","level":4,"score":0.4180999994277954},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4004000127315521},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3716999888420105},{"id":"https://openalex.org/C123915805","wikidata":"https://www.wikidata.org/wiki/Q15332826","display_name":"Angiotensin II receptor type 1","level":4,"score":0.34060001373291016},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.328000009059906},{"id":"https://openalex.org/C140608501","wikidata":"https://www.wikidata.org/wiki/Q7318358","display_name":"Review article","level":2,"score":0.30390000343322754},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.30079999566078186},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.2992999851703644},{"id":"https://openalex.org/C2910553456","wikidata":"https://www.wikidata.org/wiki/Q285044","display_name":"Angiotensin Receptor Blockers","level":4,"score":0.2987000048160553},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.2727999985218048},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.2680000066757202},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.26100000739097595},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.25870001316070557},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.25769999623298645},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.2565999925136566}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:CiteSeerX.psu:10.1.1.859.6217","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.859.6217","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://orbi.ulg.ac.be/bitstream/2268/12358/1/DT2%20PREVENTION%20BOOK%202006%20final.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2145032491","https://openalex.org/W2035685269","https://openalex.org/W2334103991","https://openalex.org/W1528473361","https://openalex.org/W2741504203","https://openalex.org/W92677522","https://openalex.org/W2007617327","https://openalex.org/W2050644450","https://openalex.org/W4235538210","https://openalex.org/W131510143"],"abstract_inverted_index":{"Besides":[0],"lifestyle,":[1],"various":[2,31],"pharmacological":[3,163],"treatments":[4],"have":[5],"proven":[6],"their":[7],"efficacy":[8],"to":[9,87,169,186],"prevent":[10],"type":[11,39,63,75,117,159,194],"2":[12,40,76,118,160,195],"diabetes":[13,77,178],"in":[14,71,113,138,179],"high-risk":[15],"individuals,":[16,183],"especially":[17,42,90,137],"those":[18],"with":[19,61,127,140],"impaired":[20],"glucose":[21],"tolerance.":[22],"Major":[23],"placebo-controlled":[24],"clinical":[25],"trials":[26],"demonstrated":[27],"favourable":[28],"effects":[29,98],"of":[30,38,64,74,99,116,158,177,193],"glucose-lowering":[32],"drugs":[33],"used":[34],"for":[35,155],"the":[36,49,72,114,153,156,175,188],"treatment":[37],"diabetes,":[41,161],"metformin,":[43],"acarbose":[44],"and":[45,54,92,95,110,132,184,191],"thiazolidinediones":[46],"(glitazones),":[47],"although":[48],"distinction":[50],"between":[51],"a":[52,55,69],"masking":[53],"true":[56],"preventing":[57],"effect":[58],"is":[59],"difficult":[60],"this":[62],"drugs.":[65],"Because":[66],"obesity":[67],"plays":[68],"key-role":[70],"pathophysiology":[73],"anti-obesity":[78],"agents":[79],"may":[80,165],"also":[81],"be":[82],"considered":[83],"as":[84,103],"valuable":[85],"adjunct":[86],"diet":[88],"therapy,":[89],"orlistat,":[91],"perhaps":[93],"sibutramine":[94],"rimonabant.":[96],"The":[97],"lipid-lowering":[100],"agents,":[101],"such":[102],"statins":[104],"or":[105,171],"fibrates,":[106],"appear":[107],"rather":[108],"modest":[109],"still":[111],"controversial":[112],"prevention":[115,157],"diabetes.":[119],"In":[120,145],"contrast,":[121],"robust":[122],"consistent":[123],"results":[124],"were":[125],"reported":[126],"angiotensin":[128,133],"converting":[129],"enzyme":[130],"inhibitors":[131],"AT1":[134],"receptor":[135],"blockers,":[136],"patients":[139],"cardiovascular":[141],"disease":[142],"including":[143],"hypertension.":[144],"conclusion,":[146],"besides":[147],"lifestyle":[148],"intervention":[149],"that":[150],"should":[151],"remain":[152],"mainstay":[154],"many":[162],"approaches":[164],"offer":[166],"new":[167],"options":[168],"prevent,":[170],"at":[172,180],"least":[173],"delay,":[174],"development":[176],"high":[181],"risk":[182],"thus":[185],"reduce":[187],"ongoing":[189],"epidemics":[190],"burden":[192]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2025-10-27T00:00:00"}